Skip to main content

Table 1 Baseline characteristics

From: Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention

  n (%) or mean ± standard deviation
Age (years) 65.0 ± 8.2
Hypertension 34 (91.9%)
Diabetes 12 (32.4%)
Obesity 5 (13.5%)
Currently smoking 4 (10.8%)
Chronic kidney failure 3 (8.1%)
History of acute coronary syndrome 19 (51.4%)
Prior percutaneous coronary intervention 12 (32.4%)
Prior coronary artery bypass surgery 2 (5.4%)
Medications
 Aspirin 35 (94.6%)
 Clopidogrel 25 (67.6%)
 Angiotensin-converting enzyme inhibitors 6 (16.2%)
Angiotensin receptor blockers 21 (56.8%)
 Beta-blocker 30 (81.1%)
 Statin 31 (60.8%)
Number of coronary arteries with ≥ 50% obstruction
 1 12 (32.4%)
 2 14 (37.8%)
 3 11 (29.7%)
Number of stents (median) 2
EPC count before PCI (cells/mcl) 320
  1. EPCs endothelial progenitor cell